FILTER

FILTERED INTERVIEW RESULTS

Daara Patel

SECRETARY GENERAL, INDIAN DRUG MANUFACTURERS’ ASSOCIATION (IDMA)
"Today, India's pharmaceutical sector is a US$50 billion industry and we anticipate it growing to at least US$150 billion in less than a decade."

Jeff Luber

CEO, BINX HEALTH, INC.
"Certainly, the way healthcare is consumed has changed forever with people looking for convenient on-site and at-home solutions for care and we see this accelerating."

Peter Soelkner

MANAGING DIRECTOR, VETTER PHARMA INTERNATIONAL
"Our mission will remain to provide reliable, efficient, and safe processes from development, aseptic filling, and visual inspection to parenteral packaging in an economically, ethically, and ecologically responsible manner."

Jeffrey Nau

PRESIDENT & CEO, OYSTER POINT PHARMA
"Our mission is to bring novel and transformative therapies to the anterior (front) chamber of the eye, particularly for the treatment of ocular surface disease."

Shuang Liu

CEO & FOUNDER, CONSYNANCE THERAPEUTICS
"Although each rare disease impacts a small population, the rare disease population is estimated to be 10% of the total population, meaning 25-30 million Americans have at least one rare condition."

Jay Roberts & Robert Fremeau

PRESIDENT AND CEO & CHIEF SCIENTIFIC OFFICER, VYANT BIO
"At Vyant Bio we are reinventing how drugs are discovered for complex neurological and neurodegenerative disorders by applying a human-first approach."

Andrea Pfeifer

CO-FOUNDER & CEO, AC IMMUNE
"AC Immune is combining diagnostics and therapeutics, and it has developed the tools to enable detection and clearance of specific pathological proteins underlying neurodegenerative diseases."

Trevor P. Castor

PRESIDENT & CEO, APHIOS CORPORATION
"In 2021, we focused on introducing our green pathogen reduction technology to biotechnology and pharmaceutical companies."

Jeff Butler

PRESIDENT, AMPAC FINE CHEMICALS, AN SK PHARMTECO COMPANY
"Outside of our manufacturing capabilities, AFC is investing and featuring AMPAC Analytical given the growing demand for pharmaceutical testing services."

Louis Kassa

PRESIDENT & CEO, PENNSYLVANIA BIOTECHNOLOGY CENTER (PABC)
"Our blueprint to success has manifested in six IPOs and over US$3 billion worth of company value created."

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

Mongolia Mining 2024 - Digital Interactive

Investors once came to Mongolia for its geology yet stumbled upon its legislative framework. How competitive Mongolia has become today, we will leave our readers to judge, hoping that this report provides them with the resources to make an informed assessment.

PARTNER EVENTS